Caris Life Sciences:
Precision medicine company utilizing proprietary platforms to provide oncologists with actionable treatment data for cancer and other complex diseases. Caris Molecular Intelligence® (CMI), is Caris’ patented genomic profiling molecular testing service currently on the market, a multi-technology diagnostic which assesses 592 genes, 53 RNA, and 12 proteins to provide a molecular blueprint for personalized oncology treatment. Extensive clinical outcomes database and bioinformatics capability.
750 John Carpenter Freeway
Irving, Texas 7509
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.